semaglutide patent expiration Generic injectable could cost as little as $28 per person-year after the initial expired in April 2026 — a fraction of current branded prices — and be available in about Massive Rs 50,000 Cr Opportunity

Larger-capacity batteries can handle higher currents at the same C rating compared to smaller batteries

Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia

NICE NG28: A Major First-Line Shift The most significant structural change in NICE NG28s February 2026 update: metformin combined with an SGLT-2 inhibitor is now the standard first-line therapy for virtually all adults with type 2 diabetes, regardless of comorbidities

As such, they say their results indicate that GLP-1 receptor agonists are not associated with an increased risk of suicidal ideation, self-harm, and suicide when compared with DPP-4 inhibitors or SGLT-2 inhibitors among patients with type 2 diabetes

Quality sleep allows your body to repair and regenerate